nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

14.07.2016 | Original Article – Cancer Research

Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma

verfasst von: Andras Javorhazy, Nelli Farkas, Tamas Beothe, Csaba Pusztai, Arpad Szanto, Gyula Kovacs

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In spite of early detection of conventional renal cell carcinoma (RCC) by widespread use of abdominal imaging, approximately 10–15 % of patients will die due to disease. The aim of this study was to identify new biomarkers predicting the postoperative progression of conventional RCC.

Methods

Tissue multiarrays (TMA) of conventional RCC from a cohort of 486 patients were analysed by immunohistochemistry for expression of the transmembrane protein TMEM27, which was identified as a candidate biomarker by Affymetrix U133 Plus 2.0 array. Univariate and multivariate Cox regression models were addressed to assess cancer-specific survival in association with clinicopathological variables and TMEM27 expression. Cancer-specific survival time was estimated with Kaplan–Meier analysis, and the comparison of survival curves was made with the log-rank test.

Results

The Kaplan–Meier survival analysis indicated a poor disease-specific survival rates for tumours without TMEM27 staining. Univariate analysis revealed an association of patient survival with T stadium, grade, stage and size of tumour and TMEM27 expression in all cases as well as in the cohort of patients with postoperative tumour progression. In multivariate analysis, only T stadium and TMEM27 staining showed a significant association with postoperative cancer-specific death (p < 0.001).

Conclusions

Lack of expression of the TMEM27 in conventional RCC defines a group of patients at high risk for cancer-related death.

Nur mit Berechtigung zugänglich

Akpinar P, Kuwajima S, Krützfeldt J, Stoffel M (2005) Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic b cell proliferation. Cell Metab 2(6):385–397CrossRefPubMed

Altirriba J, Gasa R, Casas S, Ramirez-Bajo MJ, Ros S, Gutierrez-Dalmau A, Ruiz de Villa MC, Barbera A, Gomis R (2010) The role of transmembrane protein 27 (TMEM27 in islet physiology and its potential use as beta cell mass biomarker. Diabetologia 53(7):1406–1414CrossRefPubMed

Conant JL, Peng Z, Evans MF, Naud S, Cooper K (2011) Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition. J Clin Pathol 64(12):1088–1092CrossRefPubMed

Danilczyk U, Sarao R, Remy C, Benabbas C, Stange G, Richter A, Arya S, Pospisilik JA, Singer D, Camargo SM, Makrides V, Ramadan T, Verrey F, Wagner CA, Penninger JM (2006) Essential role for collectrin in renal amino acid transport. Nature 444(7122):1088–1091CrossRefPubMed

Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diametes of the young. N Engl J Med 345(13):971–980CrossRefPubMed

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403CrossRefPubMed

Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168(6):2395–2400CrossRefPubMed

Fukui K, Yang Q, Cao Y, Takahashi N, Hatakeyama H, Wang H, Wada J, Zhang Y, Marselli L, Nammo T, Yoneda K, Onishi M, Higashiyama S, Matsuzawa Y, Gonzalez FJ, Weir GC, Kasai H, Shimomura I, Miyagawa J, Wollheim CB, Yamagata K (2005) The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab 2(6):373–384CrossRefPubMed

Joseph RW, Kapur P, Serie DJ, Eckel-Passow JE, Parasramka M, Ho T, Cheville JC, Frenkel E, Rakheja D, Brugarolas J, Parker A (2014) Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma. Cancer 120(7):1059–1067CrossRefPubMed

Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA (2005) Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173(5):1496–1501CrossRefPubMed

O’Brien J, Buckley O, Doody O, Ward E, Persaud T, Torreggiani W (2008) Imaging of horseshoe kidneys and their complications. J Med Imaging Radiat Oncol 52(3):216–226CrossRefPubMed

Paret C, Schön Z, Szponar A, Kovacs G (2010) Expression of the inflammatory protein serum amyloid A1 (SAA1) in tumor cells is associated with the progression of conventional renal cell carcinoma. Eur Urol 57(5):859–866CrossRefPubMed

Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED (2009) Development and Evolution of BioScore: a biomarker panel to enhance of prognostic algorithms for clear cell renal cell carcinoma. Cancer 115(10):2092–2103CrossRefPubMedPubMedCentral

Pasquali L, d Annuncio G, Gastaldi R, Di Battista E, Calcaterra V, Larizza D, Lorini R, D Amato L (2009) Collectrin gene screening in Turner syndrome patients with kidney malformation. J Genet 88(1):105–108CrossRefPubMed

Sobin LH, Gospodarowicz MK, Wittekind C (Eds) (2009) TNM Classification of Malignant Tumours 7th Edition, Wiley-Blackwell

Verrey F, Singer D, Ramadan T, Vuille-dit-Bille RN, Mariotta L, Camargo SMR (2009) Kidney amino acid transport. Pflugers Arch – Eur. J Physiol 458(1):53–60

Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI et al (1996) Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3). Nature 384(6608):455–458CrossRefPubMed

Yamagata K, Nammo T, Sato Y, Saisho K, Shoda H, Fukui K (2007) The HNF-1a-SNARE connection. Diabetes Obes Metab 9(Suppl. 2):40–45CrossRefPubMed

Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, Wang H, Lin S, Kanwar YS, Makino H (2001) Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulatedin embryonic kidneys. J Biol Chem 276(20):17132–17139CrossRefPubMed

Zhang Y, Wada J, Yasuhara A, Iseda I, Eguchi J, Fukui K, Yang Q, Yamagata K, Hiesberger T, Igarashi P, Zhang H, Wang H, Akagi S, Kanwar YS, Makino H (2007) The role for HNF-1 b-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PlosOne 5:e414CrossRef

Titel: Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma
verfasst von: Andras Javorhazy
Nelli Farkas
Tamas Beothe
Csaba Pusztai
Arpad Szanto
Gyula Kovacs
Publikationsdatum: 14.07.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 9/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-016-2207-3

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2016

Hematologic malignancies: newer strategies to counter the BCL-2 protein

Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB

Clinical challenges with calcitonin-negative medullary thyroid carcinoma

Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany

Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers

The emerging roles of exosomes in tumor–stroma interaction

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie